Invictus MD Strategies Corp. announced that Acreage Pharms Ltd. has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR).
“We are thrilled to have obtained our sales license from Health Canada. This is the crowning milestone in our licensing journey for Invictus, as we march towards fulfilling capacity goals during this historic and important year for Canada’s cannabis industry,” said Dan Kriznic, Invictus Chairman and CEO, “We started this company in 2014 with the intention of becoming Canada’s Cannabis Company. With the granting of Acreage Pharms’ sales license and the completion of the Phase 2 structure at Acreage Pharms, two key milestones in the drive towards that intent now have been achieved. This dramatically advances our timeline for increasing our annual run-rate production capacity at our current 39,600 square foot facilities and construction plan for the 80,000 square foot Phase 3 to be completed by September 2018 in time for the adult-use market.”
The awarding of the license coincides with the launch of Invictus’ extensive retail development plan, an ongoing effort that hinges on the ownership and opening of at least 20 dispensaries in British Columbia, Alberta and Saskatchewan; supply agreements with governmental bodies and licensed producers; and securing large-scale product calls and supply agreements, as well as smaller “craft” agreements.
